Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
KYMERA THERAPEUTICS, INC. (KYMR), most recent 12 months reported: revenue $105M, net loss $299.6M, free cash flow -$237.96M. Latest balance sheet on file: liquid cash $690.99M. From SEC filings. More on KYMERA THERAPEUTICS, INC.: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): ATARA BIOTHERAPEUTICS, INC. · Autolus Therapeutics plc · GINKGO BIOWORKS HOLDINGS, INC. · Century Therapeutics, Inc. · 4D Molecular Therapeutics, Inc. · Protalix BioTherapeutics, Inc. · COMPUGEN LTD · CHAMPIONS ONCOLOGY, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.